Tzar Labs

Tzar Labs is a pioneering force in Biotechnology Research, dedicated to the development of cutting-edge cancer prognostic and diagnostic technologies. Tzar Labs specializes in discovering, building, and commercializing innovative tests that make a clinically meaningful difference in the detection and management of cancer.

The company has developed a first-of-its-kind non-invasive 'HrC' test (NIHT), recognized as the most accurate screening test for all cancers. This breakthrough technology distinguishes between non-cancer, imminent cancer, and the different stages of cancer, also serving as the first prognostic test for cancer. Tzar Labs is located at 30 Cecil Street, #21-08 Prudential Tower, Singapore, SG.

With a host of prestigious investors from the USA, Europe, and Asia, Tzar Labs is poised to revolutionize cancer diagnostics and prognostics. The team at Tzar Labs is committed to advancing healthcare through innovation. We invite the manager of Tzar Labs to create a customized and exclusive company showcase and product listing on our platform to further amplify your reach and impact.